Cargando…
Tissue Expanders and Proton Beam Radiotherapy: What You Need to Know
Proton beam radiotherapy (PBR) has gained acceptance for the treatment of breast cancer because of unique beam characteristics that allow superior dose distributions with optimal dose to the target and limited collateral damage to adjacent normal tissue, especially to the heart and lungs. To determi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505855/ https://www.ncbi.nlm.nih.gov/pubmed/28740794 http://dx.doi.org/10.1097/GOX.0000000000001390 |